In order to access this content you must be logged in and have a subscription to PL Intelligence.

PL Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.
ZymoGenetics and Merck Serono Restructure Partnership
ZymoGenetics Receives Notice from Novo Nordisk to Extend Option and License Agreement
ZymoGenetics Licenses Non-Core Assets to Seattle Life Sciences
ZymoGenetics Secures Worldwide Rights to IL-21
Bio-Discovery and ZymoGenetics announce collaboration
ZymoGenetics Licenses Recombinant Factor XIII to Novo Nordisk